BG27542A3 - Method of obtaining of 1- benzazolylalkyl- 4- substituated - Google Patents
Method of obtaining of 1- benzazolylalkyl- 4- substituatedInfo
- Publication number
- BG27542A3 BG27542A3 BG7634394A BG3439476A BG27542A3 BG 27542 A3 BG27542 A3 BG 27542A3 BG 7634394 A BG7634394 A BG 7634394A BG 3439476 A BG3439476 A BG 3439476A BG 27542 A3 BG27542 A3 BG 27542A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- benzazolylalkyl
- substituated
- obtaining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62072775A | 1975-10-08 | 1975-10-08 | |
US05/713,309 US4035369A (en) | 1975-10-08 | 1976-08-10 | 1-Benzazolylalkyl-4-substituted-piperidines |
Publications (1)
Publication Number | Publication Date |
---|---|
BG27542A3 true BG27542A3 (en) | 1979-11-12 |
Family
ID=27088773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG7634394A BG27542A3 (en) | 1975-10-08 | 1976-10-08 | Method of obtaining of 1- benzazolylalkyl- 4- substituated |
Country Status (31)
Country | Link |
---|---|
US (1) | US4035369A (el) |
JP (1) | JPS5246082A (el) |
AT (1) | AT365185B (el) |
AU (1) | AU511834B2 (el) |
BG (1) | BG27542A3 (el) |
CA (1) | CA1085853A (el) |
CH (1) | CH630915A5 (el) |
CS (1) | CS225101B2 (el) |
DE (1) | DE2645125A1 (el) |
DK (1) | DK151801C (el) |
EG (1) | EG12969A (el) |
ES (1) | ES452200A1 (el) |
FI (1) | FI63228C (el) |
FR (1) | FR2346009A1 (el) |
GB (1) | GB1532546A (el) |
GR (1) | GR61672B (el) |
HU (1) | HU174927B (el) |
IE (1) | IE43951B1 (el) |
IL (1) | IL50631A (el) |
IT (1) | IT1069293B (el) |
LU (1) | LU75954A1 (el) |
NL (1) | NL7611085A (el) |
NO (1) | NO144926C (el) |
NZ (1) | NZ182134A (el) |
PH (1) | PH15417A (el) |
PL (1) | PL106815B1 (el) |
PT (1) | PT65688B (el) |
RO (1) | RO69904A (el) |
SE (1) | SE417610B (el) |
SU (1) | SU663306A3 (el) |
YU (1) | YU39976B (el) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4200641A (en) * | 1976-12-21 | 1980-04-29 | Janssen Pharmaceutica, N.V. | 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives |
US4335127A (en) * | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
EP0034116A3 (en) * | 1980-02-11 | 1981-09-02 | Berlex Laboratories, Inc. | N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines |
US4254127A (en) * | 1980-04-03 | 1981-03-03 | Janssen Pharmaceutica, N.V. | 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives |
DE3442757A1 (de) * | 1984-11-23 | 1986-05-28 | Wella Ag, 6100 Darmstadt | Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate |
KR930005004B1 (ko) * | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
FR2702214B1 (fr) * | 1993-03-05 | 1995-04-14 | Adir | Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
GB9418326D0 (en) * | 1994-09-12 | 1994-11-02 | Lilly Industries Ltd | Pharmaceutical compounds |
ATE247114T1 (de) | 1994-09-12 | 2003-08-15 | Lilly Co Eli | Serotonergische modulatoren |
GB2308362A (en) * | 1995-12-19 | 1997-06-25 | Lilly Industries Ltd | Pharmaceutical indole derivatives |
GB9613423D0 (en) * | 1996-06-26 | 1996-08-28 | Lilly Industries Ltd | Pharmaceutical compounds |
EP2064227A2 (en) * | 2006-09-19 | 2009-06-03 | Cipla Ltd. | Processes for the preparation of ciclesonide and its crystal form |
CN101759693B (zh) * | 2008-12-23 | 2011-09-14 | 江苏恩华药业股份有限公司 | 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用 |
CA3211341A1 (en) * | 2021-03-19 | 2022-09-22 | Centre National De La Recherche Scientifique | Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE633495A (el) * | 1962-06-13 | |||
US3225052A (en) * | 1964-05-06 | 1965-12-21 | Janssen Pharmaceutica Nv | Benzimidazolinyl piperidine derivatives |
FR1573739A (el) | 1968-07-26 | 1969-07-04 | ||
US3635982A (en) * | 1969-04-08 | 1972-01-18 | American Home Prod | Amino-substituted-quinoxalinyloxazolidines and -oxazines |
-
1976
- 1976-08-10 US US05/713,309 patent/US4035369A/en not_active Expired - Lifetime
- 1976-09-22 NZ NZ182134A patent/NZ182134A/xx unknown
- 1976-09-23 AU AU18078/76A patent/AU511834B2/en not_active Expired
- 1976-09-28 PH PH18950A patent/PH15417A/en unknown
- 1976-10-01 CA CA262,478A patent/CA1085853A/en not_active Expired
- 1976-10-05 EG EG605/76A patent/EG12969A/xx active
- 1976-10-05 GR GR51849A patent/GR61672B/el unknown
- 1976-10-05 FR FR7629928A patent/FR2346009A1/fr active Granted
- 1976-10-06 GB GB41465/76A patent/GB1532546A/en not_active Expired
- 1976-10-06 IT IT51612/76A patent/IT1069293B/it active
- 1976-10-06 CH CH1265376A patent/CH630915A5/de not_active IP Right Cessation
- 1976-10-06 DE DE19762645125 patent/DE2645125A1/de active Granted
- 1976-10-07 LU LU75954A patent/LU75954A1/xx unknown
- 1976-10-07 PT PT65688A patent/PT65688B/pt unknown
- 1976-10-07 ES ES452200A patent/ES452200A1/es not_active Expired
- 1976-10-07 AT AT0745276A patent/AT365185B/de active
- 1976-10-07 JP JP51119933A patent/JPS5246082A/ja active Granted
- 1976-10-07 FI FI762865A patent/FI63228C/fi not_active IP Right Cessation
- 1976-10-07 IL IL50631A patent/IL50631A/xx unknown
- 1976-10-07 DK DK452076A patent/DK151801C/da not_active IP Right Cessation
- 1976-10-07 NL NL7611085A patent/NL7611085A/xx not_active Application Discontinuation
- 1976-10-07 PL PL1976192890A patent/PL106815B1/pl not_active IP Right Cessation
- 1976-10-07 SE SE7611137A patent/SE417610B/xx not_active IP Right Cessation
- 1976-10-07 IE IE2212/76A patent/IE43951B1/en unknown
- 1976-10-07 NO NO763424A patent/NO144926C/no unknown
- 1976-10-08 HU HU76JA771A patent/HU174927B/hu not_active IP Right Cessation
- 1976-10-08 RO RO197687960Q patent/RO69904A/ro unknown
- 1976-10-08 CS CS766511A patent/CS225101B2/cs unknown
- 1976-10-08 YU YU2480/76A patent/YU39976B/xx unknown
- 1976-10-08 BG BG7634394A patent/BG27542A3/xx unknown
- 1976-10-08 SU SU762407707A patent/SU663306A3/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG27553A3 (en) | Method of obtaining of 2- phenyl- 3- aroylxenzothiophenes | |
BG27557A4 (en) | Method of obtaining of cephemic compounds | |
BG24673A3 (en) | Method of obtaining quinazone derivatives | |
BG27548A3 (en) | Method of obtaining of carbonylsubstituated 1- sulphanylbenzimidazoles | |
BG27554A3 (en) | Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes | |
BG27542A3 (en) | Method of obtaining of 1- benzazolylalkyl- 4- substituated | |
JPS51136672A (en) | Preparation method of 33methylpyridine | |
BG24799A3 (en) | Method of obtaining benzoylureidediphenyl-esters | |
BG27355A3 (en) | Method of obtaining of 11- desoxy- 16- ariloxy- w- tetranoprostaglandines | |
JPS5280987A (en) | Method of forming can | |
BG31070A3 (en) | Method for obtaining of 11- dexoxy- 16- aryl- w- tetranoprostagine | |
BG27899A3 (en) | Method of obtaining of highdispersed cianurchloride | |
BG27543A3 (en) | Method of obtaining of n- aryl- n- (1- l- 4- piperidinyj)- arylacetamides | |
BG24801A3 (en) | Method of obtaining l-pyroglutamyl-l-prolineamide | |
JPS5280397A (en) | Popymerization method of epsilonncaprolactam | |
BG27732A3 (en) | Method of obtaining of di- substituated phenolethers of 3- amino- 2-hydroxipropane | |
BG32846A3 (en) | Method for obtaining of n- methylcarbamide | |
BG28057A4 (en) | Method of obtaining of 3- hydroxy- methylenchromanones | |
BG27555A3 (en) | Method of obtaining of derivatives of aroyl- phenilnaphtalenes | |
JPS5250560A (en) | Method of forming throughhhole | |
BG27373A3 (en) | Method of obtaining of gamapyrones | |
JPS5224962A (en) | Method of colddrolling | |
BG24228A3 (en) | Method of preparing n-alkenyl-2-aminomethylpyrrolidine | |
JPS5219680A (en) | Preparation method of chlorothianthrene | |
JPS51145588A (en) | Method of continuous phtoopolymerization |